Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/pierre-fabre-laboratories-receive-positive-chmp-opinion-for-obgemsavibegron-in-overactive-bladder-syndrome-302128768.html
https://www.contractpharma.com/contents/view_breaking-news/2024-04-04/pierre-fabre-appoints-adriana-herrera-ceo-of-new-us-affiliate/
https://www.globenewswire.com//news-release/2024/03/01/2838802/0/en/Kinnate-Biopharma-Inc-Sells-Its-Investigational-Pan-RAF-Inhibitor-Exarafenib-to-Pierre-Fabre-Laboratories.html
https://www.prnewswire.com/news-releases/pierre-fabre-laboratories-committed-to-combating-rare-pediatric-diseases-via-innovative-therapies-302069781.html
https://www.prnewswire.com/news-releases/pierre-fabre-laboratories-and-the-esperare-foundation-to-be-honored-with-the-eurordis-company-award-for-patient-engagement-2024-in-their-approach-to-co-developing-a-treatment-for-xlhed-302060935.html
https://www.fiercepharma.com/pharma/pierre-fabre-doubles-down-its-t-cell-partnership-arata-640m-deal
https://www.prnewswire.com/news-releases/european-medicines-agency-validates-pierre-fabre-laboratories-marketing-authorisation-application-for-combination-braftovi-encorafenib-and-mektovi-binimetinib-for-patients-with-brafv600-mutant-advanced-non-small-cell-lung-c-301975614.html